These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 30528182

  • 1. Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches.
    Kido LA, de Almeida Lamas C, Maróstica MR, Cagnon VHA.
    Life Sci; 2019 Jan 15; 217():141-147. PubMed ID: 30528182
    [Abstract] [Full Text] [Related]

  • 2. Association of anti-inflammatory and antiangiogenic therapies negatively influences prostate cancer progression in TRAMP mice.
    Mateus PAM, Kido LA, Silva RS, Cagnon VHA, Montico F.
    Prostate; 2019 Apr 15; 79(5):515-535. PubMed ID: 30585351
    [Abstract] [Full Text] [Related]

  • 3. Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP).
    da Silva RF, Nogueira-Pangrazi E, Kido LA, Montico F, Arana S, Kumar D, Raina K, Agarwal R, Cagnon VHA.
    J Biomed Sci; 2017 May 12; 24(1):31. PubMed ID: 28499383
    [Abstract] [Full Text] [Related]

  • 4. Anti-inflammatory therapies in TRAMP mice: delay in PCa progression.
    Kido LA, Montico F, Sauce R, Macedo AB, Minatel E, Costa DB, Carvalho JE, Pilli RA, Cagnon VH.
    Endocr Relat Cancer; 2016 Apr 12; 23(4):235-50. PubMed ID: 26772819
    [Abstract] [Full Text] [Related]

  • 5. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.
    Gupta S, Ahmad N, Marengo SR, MacLennan GT, Greenberg NM, Mukhtar H.
    Cancer Res; 2000 Sep 15; 60(18):5125-33. PubMed ID: 11016639
    [Abstract] [Full Text] [Related]

  • 6. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
    Raina K, Rajamanickam S, Singh RP, Deep G, Chittezhath M, Agarwal R.
    Cancer Res; 2008 Aug 15; 68(16):6822-30. PubMed ID: 18701508
    [Abstract] [Full Text] [Related]

  • 7. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
    Raina K, Blouin MJ, Singh RP, Majeed N, Deep G, Varghese L, Glodé LM, Greenberg NM, Hwang D, Cohen P, Pollak MN, Agarwal R.
    Cancer Res; 2007 Nov 15; 67(22):11083-91. PubMed ID: 18006855
    [Abstract] [Full Text] [Related]

  • 8. Reactive stroma in the prostate during late life: The role of microvasculature and antiangiogenic therapy influences.
    Montico F, Kido LA, San Martin R, Rowley DR, Cagnon VH.
    Prostate; 2015 Oct 15; 75(14):1643-61. PubMed ID: 26184673
    [Abstract] [Full Text] [Related]

  • 9. Deletion of p21/Cdkn1a confers protective effect against prostate tumorigenesis in transgenic adenocarcinoma of the mouse prostate model.
    Jain AK, Raina K, Agarwal R.
    Cell Cycle; 2013 May 15; 12(10):1598-604. PubMed ID: 23624841
    [Abstract] [Full Text] [Related]

  • 10. Prostatic angiogenic responses in late life: antiangiogenic therapy influences and relation with the glandular microenvironment in the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Montico F, Kido LA, Hetzl AC, Cagnon VH.
    Prostate; 2015 Apr 01; 75(5):484-99. PubMed ID: 25521760
    [Abstract] [Full Text] [Related]

  • 11. Lobe-specific lineages of carcinogenesis in the transgenic adenocarcinoma of mouse prostate and their responses to chemopreventive selenium.
    Wang L, Zhang J, Zhang Y, Nkhata K, Quealy E, Liao JD, Cleary MP, Lü J.
    Prostate; 2011 Sep 15; 71(13):1429-40. PubMed ID: 21360561
    [Abstract] [Full Text] [Related]

  • 12. Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.
    Raghow S, Kuliyev E, Steakley M, Greenberg N, Steiner MS.
    Cancer Res; 2000 Aug 01; 60(15):4093-7. PubMed ID: 10945615
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice.
    Kelavkar UP, Glasgow W, Olson SJ, Foster BA, Shappell SB.
    Neoplasia; 2004 Aug 01; 6(6):821-30. PubMed ID: 15720809
    [Abstract] [Full Text] [Related]

  • 14. Differential attenuation of oxidative/nitrosative injuries in early prostatic neoplastic lesions in TRAMP mice by dietary antioxidants.
    Tam NN, Nyska A, Maronpot RR, Kissling G, Lomnitski L, Suttie A, Bakshi S, Bergman M, Grossman S, Ho SM.
    Prostate; 2006 Jan 01; 66(1):57-69. PubMed ID: 16114064
    [Abstract] [Full Text] [Related]

  • 15. Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism.
    Singh KB, Kim SH, Hahm ER, Pore SK, Jacobs BL, Singh SV.
    Carcinogenesis; 2018 May 28; 39(6):826-837. PubMed ID: 29668854
    [Abstract] [Full Text] [Related]

  • 16. Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis.
    Bono AV, Pannellini T, Liberatore M, Montironi R, Cunico SC, Cheng L, Sasso F, Musiani P, Iezzi M.
    Anal Quant Cytol Histol; 2010 Jun 28; 32(3):136-45. PubMed ID: 20701066
    [Abstract] [Full Text] [Related]

  • 17. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP).
    Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavish A.
    Cancer Res; 2001 Sep 15; 61(18):6777-82. PubMed ID: 11559550
    [Abstract] [Full Text] [Related]

  • 18. Use of transgenic mice as models for prostate cancer chemoprevention.
    Nguewa PA, Calvo A.
    Curr Mol Med; 2010 Nov 15; 10(8):705-18. PubMed ID: 20937024
    [Abstract] [Full Text] [Related]

  • 19. Chemopreventive Effects of Korean Angelica versus Its Major Pyranocoumarins on Two Lineages of Transgenic Adenocarcinoma of Mouse Prostate Carcinogenesis.
    Tang SN, Zhang J, Wu W, Jiang P, Puppala M, Zhang Y, Xing C, Kim SH, Jiang C, Lü J.
    Cancer Prev Res (Phila); 2015 Sep 15; 8(9):835-44. PubMed ID: 26116406
    [Abstract] [Full Text] [Related]

  • 20. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.
    Escara-Wilke J, Keller JM, Ignatoski KM, Dai J, Shelley G, Mizokami A, Zhang J, Yeung ML, Yeung KC, Keller ET.
    Prostate; 2015 Feb 15; 75(3):292-302. PubMed ID: 25327941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.